Abveris Deploys the Berkeley Lights Beacon® Platform for Antibody Discovery
CANTON, Mass.–(BUSINESS WIRE)–Abveris, Inc., a leader in contract research antibody discovery, today announced the deployment of the Berkeley Lights, Inc.…
Pharmaceuticals, Biotechnology and Life Sciences
CANTON, Mass.–(BUSINESS WIRE)–Abveris, Inc., a leader in contract research antibody discovery, today announced the deployment of the Berkeley Lights, Inc.…
Findings will support application for European marketing authorization and augment body of data supporting efficacy and utility of its ready-to-use,…
Company Co-Founder and Chief Technology Officer Receives Distinguished Judith Stitt Best Abstract Award for Data Presented at the American Brachytherapy…
Additions strengthen management team and position company to advance portfolio of medicines targeting RNA-mediated diseases into the clinic SAN DIEGO–(BUSINESS…
SAN FRANCISCO–(BUSINESS WIRE)–#DNA–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA…
VT-1161 is a potent antifungal therapy with the potential to treat a range of fungal infections, including those resistant to…
Leveraging innovative technology to orchestrate cross functional teamwork and multichannel interactions with external stakeholders DANBURY, Conn. & RESEARCH TRIANGLE PARK,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global bacterial disease diagnostics market is expected to post a CAGR of close to 6% during the period…
In CLL/SLL Patients in the DUO Study, Duvelisib Treatment Rapidly Increased Lymphocytes and Resulted in Shrinkage of Lymph Nodes, With…